Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Severity of Scratching Useful Assessment in Trials

J Invest Dermatol; ePub 2017 Dec 11; Udkoff, et al

Severity of scratching may be a useful endpoint in clinical trials and practice across the gamut of pruritic disorders, according to a recent study. Researchers sought to validate and test the severity of scratching as an objective measure of itch (4-point ordinal scale ranging from 0 [not present] to 3 [very prominent] based on the observation of scratching lesions). They performed a prospective outpatient study using questionnaires and evaluations by a dermatologist in adults with atopic dermatitis (AD) (n=261). Severity of scratching best correlated with patient-reported global AD severity (Kendal’s Tau=0.336), Numeric Rating Scale (NRS) of itch in the past 24 hours (0.266) and 3 days (0.296). They found:

  • Severity of scratching showed responsiveness over time.
  • Patient’s experiencing ≥1-point improvement of scratching severity had significantly lower NRS-itch in the past 3 days (Wilcoxon rank sum test), 5-D itch scale, and Patient Oriented Eczema Measure (POEM) scores.
  • There was a significant decrease in scratching severity for patients experiencing ≥4-point improvement of NRS-itch in the past 3 days (Fisher’s exact test), POEM, and Dermatology Life Quality Index (DLQI).
Citation:

Udkoff J, Silverberg JI. Validation of scratching severity as an objective assessment for itch. [Published online ahead of print December 11, 2017]. J Invest Dermatol. doi:10.1016/j.jid.2017.11.028.

This Week's Must Reads

Link Between AD and Autoimmune Disorders, J Am Acad Dermatol; ePub 2018 Oct 1; Narla, et al

Predictors of Mucosal Melanoma Survival, J Am Acad Dermatol; ePub 2018 Oct 5; Altieri, et al

Prevalence of Acne Vulgaris Among Patients with HS, J Am Acad Dermatol; ePub 2018 Oct 1; Wertenteil, et al

Skin Disease Epidemiology in a Diverse Population, J Drugs Dermatol; 2018 Oct; Gaulding, et al

Psoriasis Treatment Receives Tentative FDA Approval, Bausch Heath news release; 2018 Oct 8

Must Reads in Atopic Dermatitis

Link Between AD and Autoimmune Disorders, J Am Acad Dermatol; ePub 2018 Oct 1; Narla, et al

Pain and Itch: A Dual Burden in Atopic Dermatitis, Dermatitis; ePub 2018 Aug 31; Maarouf, et al

Sleep Impairment Common in Persons with AD, Dermatitis; ePub 2018 Aug 31; Li, Fishbein, et al

Atopic Dermatitis Puts Heavy Burden on Patients, Ann Asthma Allergy Immunol; ePub 2018 Jul 16; Silverberg, et al

AD Patients’ Reactions to Personal Care Products, J Am Acad Dermatol; ePub 2018 Jul 24; Rastogi, et al